In the A549 lung cancer cell line exposed to nutlin-3a, a classic p53 activator that is an antagonist of the negative regulator of p53, MDM2 protein, the treatment induces a strong (at least fourfold) up-regulation of 94 genes. This evidence concerns the gene TP53 and lung carcinoma.